Active Litigation
Taxotere Lawsuit Facts
TorHoerman Law is actively accepting claims for the Taxotere Lawsuit.
Active Litigation
TorHoerman Law is actively accepting claims for the Taxotere Lawsuit.
On this page, we’ll discuss the Taxotere Eye Injury Lawsuit, the current status of the Taxotere Vision Loss Lawsuit, side effects of taking Taxotere, how a Taxotere Lawyer can help, and much more.
The chemotherapy drug Taxotere (docetaxel), commonly used to treat breast cancer, has been linked to various severe eye injuries, including vision problems and irreversible eye damage.
Many patients undergoing Taxotere treatment have reported complications like excessive tearing, blurry vision, and even permanent vision loss.
These injuries can significantly impact quality of life, making everyday tasks more difficult and creating new health challenges for cancer survivors already enduring the effects of treatment.
The Taxotere Eye Injury Lawsuit seeks to compensate individuals who have suffered such vision-related issues as a result of their Taxotere use.
Vision damage lawsuits have been consolidated into multidistrict litigation (MDL) in the US District Court for the Eastern District of Louisiana, where the Taxotere Hair Loss MDL is currently centralized.
Our lawyers are currently only accepting Taxotere Lawsuits from individuals who have suffered vision loss or eye injuries related to Taxotere use.

If you or a loved one experienced eye injuries or suffered vision loss after Taxotere use, you may be eligible to file a Taxotere Eye Injury Lawsuit and pursue financial compensation.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify for the Taxotere Eye Injury Lawsuit instantly.
Our law firm is committed to helping people filing Taxotere Lawsuits seek justice.
We understand the gravity of your situation, and we are sensitive to your needs as a client.
Reach out to our Taxotere Lawyers for more information and to find out how we can help you.

Taxotere lawsuits involve breast cancer survivors and others who were treated with Taxotere, a widely used chemotherapy drug (docetaxel), alleging that the drug’s manufacturer, Sanofi-Aventis, failed to adequately warn doctors and Taxotere patients about serious risks to the eyes.
Among the alleged harms are excessive tearing (epiphora), blocked tear ducts (canalicular stenosis and punctal stenosis), blurry vision, irritation, and in some cases irreversible vision impairment.
These side effects may arise even if symptoms seem mild at first, especially for those undergoing treatment over multiple cycles of weekly docetaxel treatments.
Since 2019, the litigation has focused on Sanofi’s failure to adequately warn patients and medical professionals of these risks, leaving thousands to endure unexpected complications beyond their cancer treatment.
The cases are consolidated into multidistrict litigation (MDL) No. 3023 in the Eastern District of Louisiana, separate from the Taxotere Hair Loss MDL (MDL-2740), where amended short form complaints have been filed by numerous plaintiffs.
These complaints seek to hold Sanofi responsible not only for failing to warn but also for enabling unnecessary suffering among cancer patients who trusted that risks were disclosed.
Plaintiffs argue that Sanofi, the drug’s manufacturer, had knowledge of eye-related adverse effects long before warning labels reflected the severity, and that the lack of prompt, clear disclosure meant many survivors did not recognize symptoms early enough to avoid long-term damage.
The litigation asserts that Taxotere, while effective against cancer cells, poses these added burdens that should have been communicated to oncologists and patients so that people could make more informed choices.
If you or a loved one were administered Taxotere and later experienced watery or overly tearing eyes, eye irritation, blurred vision, or other eye-related complications, you may be eligible to seek compensation.
Our legal team can review whether your case fits under the current MDL, help you understand your rights, document injuries, and pursue damages for medical costs, repair surgeries, vision care, and emotional suffering.
Taxotere, also known by its active ingredient docetaxel, is an anticancer agent commonly used during chemotherapy to treat various forms of cancer such as breast cancer, prostate cancer and lung cancer.
Taxotere combats cancer by over-stabilizing the structure of cancer cells.
This method prevents cancer cells from breaking down and reproducing, thereby reducing the growth and spread of cancerous cells within the body.
Taxotere is part of the “taxane” family of cytotoxic drugs, a class of chemotherapy treatments made from plant alkaloids.
Taxotere was developed by Sanofi-Aventis and first approved for limited use in May 1996 by the U.S. Food and Drug Administration, meant to help treat individuals with locally advanced or metastatic breast cancer.
It was later approved by the FDA for wider use in 2004.
Taxotere is commonly prescribed to treat patients with:
The Judicial Panel on Multidistrict Litigation (JPML) consolidated Taxotere vision loss cases into multidistrict litigation (MDL 3023) in the Eastern District of Louisiana.
The Taxotere litigation will be handled by Judge Jane Triche Milazzo.
The MDL for Taxotere hair-loss litigation (MDL 2740) is also centralized in the same district court and handled by the same judge.
As mentioned previously, our law firm is only handling Taxotere Lawsuits related to vision damage, and we are not accepting clients for the Taxotere Hair Loss Lawsuits.
Taxotere has been found to lead to potentially permanent damage to the eyes and lacrimal obstruction.
The chemotherapy drug has been linked to the onset of serious eye injury.
Patients treated with Taxotere who experience symptoms relating to vision loss, watery eyes, and other side effects of the cancer treatment should seek immediate treatment from a medical professional.
Timely intervention is important with vision problems related to Taxotere.

Taxotere eye injuries include:
Taxotere’s side effects can severely impact an individual’s quality of life.
Taxotere impacts the lacrimal system, the bodily system that includes tear ducts and the structures responsible for tear production and drainage.
Taxotere enters into the tear film, and build-up of the drug may lead to scarring of the lacrimal drainage apparatus and permanent occlusion (blockage).
When the lacrimal ducts or tear ducts are obstructed, bacteria buildup can occur causing infection that can lead to inflammation next to the eye.
If the condition is allowed to worsen, permanent vision loss (cystoid macular edema) is possible.
Sanofi failed to warn and inform about Taxotere’s vision side effects (especially Epiphora) and, as such, thousands of cancer patients who use the chemotherapy drug to combat their cancer have to suffer additional potentially permanent damage.
Canalicular Stenosis and Punctal Stenosis involve the narrowing, scarring, or complete obstruction of the canaliculus or punctum — critical structures in the eye’s tear drainage system.
These conditions prevent normal tear drainage, causing chronic watery eyes (epiphora), irritation, and, in severe cases, permanent vision problems.
In individuals treated with the chemotherapy drug Taxotere, components of the drug can secrete into the tear film, accumulating within the lacrimal (tear) drainage system and resulting in inflammation and scarring.
This type of irreversible damage often requires invasive procedures, including surgery, to restore function or relieve symptoms, and, in some cases, even long-term medical management.
Studies have shown that Taxotere-associated canalicular stenosis can severely impact quality of life due to persistent, painful eye conditions.
The drug’s manufacturer has faced criticism for failing to warn users of these serious risks, leading to legal actions and advocacy for greater transparency around Taxotere’s side effects.
If left untreated, affected individuals might not be able to drain tears naturally, leading to the excessive tearing, “Epiphora” or excessive tearing/watery eyes, other health effects, and the potential need for corrective surgery.
Breast cancer patients often take a number of medications and chemotherapy drugs to manage their disease.
With the multitude of medications come side effects that may be difficult to pinpoint the source of.
Taxotere side effects, such as watery eyes and other eye injuries, could be hard to identify as coming from the chemo drug.
Doctors and eye specialists may also misdiagnose eye conditions related to Taxotere use as allergies or other side effects, not knowing the full scope of the dangers related to conditions like Canalicular Stenosis, Punctal Stenosis, Lacrimal Duct Obstruction, Epiphora, and more.
If you took Taxotere and are now suffering from chronic watery eyes or other eye injuries that can potentially be traced back to your use of the chemo drug, get in touch with a Lacrimal Specialist or Ocular Plastic Surgeon as soon as possible.
These sorts of doctors will have a keen understanding of Taxotere-related eye injuries and side effects.
Patients who have developed eye injuries such as canalicular stenosis and punctal stenosis due to Taxotere exposure require specialized medical interventions to restore proper tear drainage and alleviate symptoms.
Canalicular stenosis involves the narrowing or blockage of the canaliculi, the channels that drain tears from the eye into the nasal cavity.
Treatment options include:
Punctal stenosis refers to the narrowing or blockage of the puncta, the small openings on the eyelid margins that initiate tear drainage.
Treatment approaches include:
Early diagnosis and intervention are crucial to prevent permanent damage to the lacrimal drainage system.
Patients experiencing symptoms such as excessive tearing, eye irritation, or recurrent eye infections after Taxotere treatment should consult an ophthalmologist promptly.
TorHoerman Law is accepting lawsuits for individuals in all 50 states who have suffered permanent vision damage following the use of the chemotherapy drug Taxotere (docetaxel).
If you’ve experienced persistent watery eyes and other negative side effects after the completion of Taxotere chemotherapy treatment, you may be eligible to join the Taxotere litigation.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify for the Taxotere Lawsuit instantly.

Our team of Taxotere Eye Injury Lawyers is here to guide you throughout the legal process, protecting your rights and helping you complete the steps necessary to pursue compensation.
If you believe that you may qualify to participate in a Taxotere lawsuit, the first step you should take is to mitigate injuries and future potential damages.
In order to properly mitigate costs, seek proper medical treatment right away, follow your doctor’s orders.
You should then familiarize yourself with the civil litigation process so that you know what is to come of your Taxotere lawsuit.
Hiring a personal injury lawyer to act as your Taxotere lawyer is an important step.
Be sure to ask plenty of questions about your potential lawyer’s experience, payment structure, and anything else you deem to be important.
Your Taxotere lawyer will work to build a strong case to prove that liability for your injuries falls on Sanofi-Aventis, the manufacturer.
An experienced attorney will help file legal documents on your behalf and generally work to gain you compensation for your injuries in the form of a settlement or verdict.
Attorneys will also help gather evidence and assess damages.

Together with your attorney, you will work to gather evidence to show liability.
Gathering evidence is a crucial part of building a strong case, and includes all tangible things related to your case and related diagnosis.
Potential evidence in a Taxotere Lawsuit may include:
Assessing damages that you incurred from your injuries is another important step to take with the help of an experienced attorney.
Damages include all economic and non-economic losses incurred as the result of an injury.

Potential damages in a Taxotere Lawsuit may include:
Your state’s statute of limitations may impact the timeframe you have to file a Taxotere lawsuit after your injuries first became apparent and/or were diagnosed, so be sure to reach out to a Taxotere lawyer as soon as possible to start the litigation process.
TorHoerman Law has a dedicated team of dangerous drugs lawyers who are experienced with litigating on behalf of individuals who suffered injuries and losses at no fault of their own.
We are now accepting clients for Taxotere Eye Injury Lawsuits in all 50 states.
If you or a loved one suffered eye injury or vision loss after Taxotere use, you may be eligible join others in filing Taxotere Eye Damage Lawsuits.
Contact TorHoerman Law for a free consultation.
You can also use the chatbot on this page to find out if you qualify for the Taxotere Vision Damage Lawsuit instantly.
We operate on a contingency fee basis, so our clients do not ever pay any legal fees until after they have been awarded compensation.
No compensation? No fees.
Reach out to the Taxotere Vision Loss Lawyers at TorHoerman Law for more information and to find out how we can help you seek justice.
The Taxotere Vision Loss Lawsuit claims that the chemotherapy drug Taxotere has been linked to multiple eye injuries and vision problems in breast cancer patients.
These eye injuries and symptoms include:
Eye injuries associated with Taxotere can lead to painful conditions that require immediate medical attention, and some people filing Taxotere lawsuits have experienced permanent visual changes due to chronic irritation and adverse reactions.
Individual Taxotere Lawsuit settlement amounts are yet to be determined.
The Taxotere Eye Injury Lawsuit is ongoing, and as more developments occur, we will have a better idea of what to expect for individual Taxotere settlements.
However, our Taxotere Lawyers estimate that individual Taxotere Lawsuit settlement amounts may range between $20,000 to a few hundred thousands dollars depending on the circumstances of an individual, their damages, and also the direction of the Taxotere litigation.
These projections are merely estimates based on prior product liability and dangerous drug lawsuits.
These estimates are by no means a guarantee of financial compensation in the Taxotere Eye Injury Lawsuit.
Our firm represents clients on a contingency fee basis, meaning we do not charge any legal fees unless we successfully secure compensation for injuries related to Taxotere.
This fee structure helps alleviate financial stress for individuals dealing with symptoms such as blurred vision, severe abdominal pain, and permanent hair loss related to the chemotherapy drug Taxotere.
With no out-of-pocket fees required, you can focus on managing side effects like twitching, dizziness, and fluid retention without the burden of legal expenses upfront.
If you or a loved one has suffered eye injuries, such as cystoid macular edema, chronic excessive tearing, or vision issues, after receiving a Taxotere chemotherapy treatment, you may qualify to file a Taxotere lawsuit.
Our legal team is actively helping individuals who’ve experienced severe side effects like irritated skin, dizziness, and permanent vision damage.
To learn more, use our chatbot on this page for an instant case evaluation or contact our firm directly to discuss your eligibility for the Taxotere Eye Injury MDL.
The Taxotere Hair Loss Lawsuit centers on claims that the breast cancer chemotherapy drug causes permanent scalp alopecia.
These lawsuits are separate from the ongoing Taxotere Eye Injury MDL and are centralized in Taxotere Hair Loss MDL 2740. Plaintiffs argue that Sanofi, the drug’s manufacturer, knew for decades that cancer patients taking Taxotere faced an increased risk of irreversible hair loss but failed to provide adequate warnings.
Sanofi only updated its FDA-approved label in 2015 to reflect permanent alopecia as a possible side effect.
The litigation claims that patients were not properly informed of this risk and were denied the opportunity to choose other chemotherapy drugs that did not carry the same risk profile.
As a result, plaintiffs are seeking compensation for damages tied to the physical, emotional, and financial toll of permanent alopecia.
Sanofi knew since the 1990s that cancer patients taking Taxotere had an increased to suffer permanent alopecia related to the drug.
Sanofi did not provide adequate warning to patients of hair-loss side effects, prompting lawsuits.
At TorHoerman Law, we are currently only accepting Taxotere eye injury cases and we are not part of the products liability litigation related to permanent hair loss or temporary hair loss.
To learn more, use our chatbot on this page for an instant case evaluation or contact our firm directly to discuss your eligibility for the Taxotere Eye Injury MDL.
There is no Taxotere Class Action Lawsuit, but lawsuits related to eye injuries and hair loss are centralized into multidistrict litigation (MDL).
There are two separate MDLs related to Taxotere.
One MDL is strictly for eye injuries and vision loss related cases, which TorHoerman Law is accepting.
The other MDL relates to patients who have suffered permanent hair loss as a result of Taxotere use.
TorHoerman Law is not accepting cases related to permanent hair loss or alopecia.
In the MDL, compensation is awarded based on individual cases, taking into account unique circumstances such as severity of symptoms like permanent hair loss and blurred vision, rather than a one-size-fits-all class action approach.
This distinction ensures that each patient’s specific injuries and damages are fairly considered.
Taxotere’s treatment plan typically runs at three-week intervals, but other treatment options recommend a weekly dose.
Fewer trips to the doctor for treatment make Taxotere more attractive to both patients and doctors.
Taxotere has also been approved for administration outside of the hospital (in 60-100 mg/m2 doses).
Similar chemotherapy treatments require hospitalization to cope with extended infusion times.
As is warned on the Taxotere label, toxic death occurs in around 2% of metastatic breast cancer patients and about 11.5% of patients with other tumor types involving abnormal liver function who are using Taxotere.
Yes, Taxotere remains widely used to treat breast cancer and other cancers despite reports of severe side effects such as blurred vision, cystoid macular edema, and permanent hair loss.
In fact, Taxotere remains one of the most prescribed drugs within its class (taxane), with an estimated 75% of breast cancer patients receiving this chemotherapy drug.
Taxotere treatment does not always require hospital stays, making it a more convenient choice, though patients should be informed of risks such as eye injuries, including lacrimal duct obstruction and painful eye conditions.

Tor Hoerman has represented injured individuals for more than 30 years, with experience spanning individual personal injury cases and nationwide mass tort litigation. His work includes car accidents, catastrophic injuries, product liability claims, and other serious injury cases. Tor has served in court-appointed leadership roles in national litigation and tried cases involving major corporate defendants.
TorHoerman Law’s legal content is researched and written by our editorial team and attorneys for legal accuracy, clarity, and relevance. We rely on statutes, court records, government publications, medical research, and other authoritative sources when applicable. This page provides general legal information and does not constitute legal advice.
TorHoerman Law reviews its legal content for factual accuracy, current information, and relevant legal context before publication and as material developments occur. This article is provided for general informational purposes and does not constitute legal advice. For guidance about a specific case, contact TorHoerman Law.
You can learn more about this topic by visiting any of our Taxotere Lawsuit pages listed below:
A serious injury can change your life.

TorHoerman Law represents people whose lives have been disrupted by serious injuries, unsafe products, and negligence. Our attorneys handle individual personal injury cases as well as national mass tort lawsuits involving major corporations.
Founded in 2009, our legal team brings more than 100 years of combined experience handling serious injury and complex civil litigation.
Do you believe you’re entitled to compensation?
Use our Instant Case Evaluator to find out in as little as 60 seconds!

In this case, we obtained a verdict of $495 Million for our client’s child who was diagnosed with Necrotizing Enterocolitis after consuming baby formula manufactured by Abbott Laboratories.

In this case, we were able to successfully recover $20 Million for our client after they suffered a Toxic Tort Injury due to chemical exposure.

In this case, we were able to successfully recover $103.8 Million for our client after they suffered a COX-2 Inhibitors Injury.

In this case, we were able to successfully recover $4 Million for our client after they suffered a Traumatic Brain Injury while at daycare.

In this case, we were able to successfully recover $2.8 Million for our client after they suffered an injury due to a Defective Heart Device.
A serious injury can change your life.